Brevican knockdown reduces late-stage glioma tumor aggressiveness

Journal of Neuro-Oncology

Volumn 120, Issue 1, 2014, Pages 63-72

  Dwyer, Chrissa A ^a   Bi, Wenya Linda ^b,c   Viapiano, Mariano S ^b,c   Matthews, Russell T ^a,d  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b YALE UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Brevican; Central nervous system; Glioma; Neural extracellular matrix; Proteoglycan

Indexed keywords

BREVICAN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DELTA LIKE 3; TRANSCRIPTION FACTOR MASH1; UNCLASSIFIED DRUG; BCAN PROTEIN, RAT; SMALL INTERFERING RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCAN GENE; CANCER STEM CELL; CONTROLLED STUDY; GLIOMA; GLIOMA CELL LINE; GLIOMA INITIATING CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INVASIVE CARCINOMA; MOUSE; NONHUMAN; OVERALL SURVIVAL; RAT; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VOLUME; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; BRAIN TUMOR; CELL DIFFERENTIATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; FEMALE; GENETICS; LEWIS RAT; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR CELL CULTURE;

ADULT; ANIMALS; BRAIN; BRAIN NEOPLASMS; BREVICAN; CELL DIFFERENTIATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; FEMALE; GLIOMA; HUMANS; NEOPLASTIC STEM CELLS; PROGNOSIS; RATS; RATS, INBRED LEW; RNA, SMALL INTERFERING; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 84910133783     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1541-z     Document Type: Article

References (35)

1. Swartz MA, Iida N, Roberts EW, Sangaletti S, Wong MH et al (2012) Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res 72:2473–2480
2. Tanaka S, Louis DN, Curry WT, Batchelor TT, Dietrich J (2013) Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol 10:14–26
3. Chen J, McKay RM, Parada LF (2012) Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell 149:36–47
4. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG (2004) Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36:1046–1069
5. Filatova AAT, Garvalov BK (2013) The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment. Biochim Biophys Acta 1830:2496–2508
6. Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE et al (2010) Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6:421–432
7. Lathia JD, Li M, Hall PE, Gallagher J, Hale JS et al (2012) Laminin alpha 2 enables glioblastoma stem cell growth. Ann Neurol 72:766–778
8. Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H (2012) The brain tumor microenvironment. Glia 60:502–514
9. Jaworski DM, Kelly GM, Hockfield S (1994) BEHAB, a new member of the proteoglycan tandem repeat family of hyaluronan-binding proteins that is restricted to the brain. J Cell Biol 125:495–509
10. Jaworski DM, Kelly GM, Hockfield S (1995) The CNS-specific hyaluronan-binding protein BEHAB is expressed in ventricular zones coincident with gliogenesis. J Neurosci 15:1352–1362
11. Yamada H, Watanabe K, Shimonaka M, Yamaguchi Y (1994) Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J Biol Chem 269:10119–10126
12. Jaworski DM, Kelly GM, Piepmeier JM, Hockfield S (1996) BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines. Cancer Res 56:2293–2298
13. Gunther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S et al (2008) Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 27:2897–2909
14. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157–173
15. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98–110
16. Gary SC, Zerillo CA, Chiang VL, Gaw JU, Gray G et al (2000) cDNA Cloning, chromosomal localization, and expression analysis of human BEHAB/brevican, a brain specific proteoglycan regulated during cortical development and in glioma. Gene 256:139–147
17. Matthews RT, Gary SC, Zerillo C, Pratta M, Solomon K et al (2000) Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member. J Biol Chem 275:22695–22703
18. Nutt CL, Zerillo CA, Kelly GM, Hockfield S (2001) Brain enriched hyaluronan binding (BEHAB)/brevican increases aggressiveness of CNS-1 gliomas in Lewis rats. Cancer Res 61:7056–7059
19. Viapiano MS, Bi WL, Piepmeier J, Hockfield S, Matthews RT (2005) Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas. Cancer Res 65:6726–6733
20. Viapiano MS, Hockfield S, Matthews RT (2008) BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion. J Neurooncol 88:261–272
21. Viapiano MS, Matthews RT, Hockfield S (2003) A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma. J Biol Chem 278:33239–33247
22. Zhang H, Kelly G, Zerillo C, Jaworski DM, Hockfield S (1998) Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion in vivo. J Neurosci 18:2370–2376
23. Hu B, Kong LL, Matthews RT, Viapiano MS (2008) The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility. J Biol Chem 283:24848–24859
24. Lu R, Wu C, Guo L, Liu Y, Mo W et al (2012) The role of brevican in glioma: promoting tumor cell motility in vitro and in vivo. BMC Cancer 12:607
25. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A et al (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:7011–7021
26. Bottenstein JE, Sato GH (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 76:514–517
27. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L et al (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33:401–406
28. Matsuki T, Matthews RT, Cooper JA, van der Brug MP, Cookson MR et al (2010) Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment. Cell 143:826–836
29. Dwyer CA, Baker E, Hu H, Matthews RT (2012) RPTPzeta/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1. Neuroscience 220:47–61
30. Rosen GD, Harry JD (1990) Brain volume estimation from serial section measurements: a comparison of methodologies. J Neurosci Methods 35:115–124
31. Kruse CA, Molleston MC, Parks EP, Schiltz PM, Kleinschmidt-DeMasters BK et al (1994) A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma. J Neurooncol 22:191–200
32. Rheinbay E, Suva ML, Gillespie SM, Wakimoto H, Patel AP et al (2013) An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. Cell Rep 3:1567–1579
33. Ligon KL, Huillard E, Mehta S, Kesari S, Liu H et al (2007) Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 53:503–517
34. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821–5828
35. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401